Guobang Pharma Ltd. (605507.SS) SHH
15.56
-0.07999973(-0.51%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
15.56
-0.07999973(-0.51%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4003
First IPO Date
August 02, 2021
| Name | Title | Pay | Year Born |
| Xing Cheng Shi | CFO & Accounting Supervisor | 0 | 1977 |
| Yuda Gong | CFO & Director | 0 | 1968 |
| Deguang Peng | Board Secretary | 0 | 1991 |
| Ligao Yao | Vice President & Director | 0 | 1976 |
| Qibin Li | Vice President & Director | 0 | 1983 |
| Shixue Liao | President & Director | 0 | 1975 |
| Fangfang Lu | Vice President | 0 | 1977 |
Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations. The company was founded in 1996 and is based in Xinchang, China.